https://www.selleckchem.com/products/lc-2.html
Our study indicates that the GLP-1 pathway plays a critical role in microglia-reactive astrocyte associated neuroinflammation in AD and the effects of NLY01 are primarily mediated through a direct action on Aβ-induced GLP-1R+ microglia, contributing to the inhibition of astrocyte reactivity. These results show that targeting upregulated GLP-1R in microglia is a viable therapy for AD and other neurodegenerative disorders. Acute respiratory distress syndrome (ARDS) is a leading cause of morbidity and mortality in the intensive care unit. Bio
Like
Comment
Share
